Stage IVA Squamous Cell Carcinoma of the Oropharynx Recruiting Phase Trials for Cetuximab (DB00002)

IndicationStatusPhase
DBCOND0029848 (Stage IVA Squamous Cell Carcinoma of the Oropharynx)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02177838Cetuximab and Radiation Therapy in Treating Patients With Stage III-IV Head and Neck CancerTreatment